ROUBAIX, France, February 24 /PRNewswire/ -- OVH, the leading French hosting service, is launching a top of the range system designed for professionals with key requirements in terms of resources, performance and also service-sharing. Covering a wide range of prices, and corresponding services, the HG range consists of the ultimate in customized servers to meet company requirements.

Meeting customers' most critical needs

In marketing its new range, OVH is innovating yet again, as the HG 2009 consists of fully-customizable servers. This means that customers can customize the configuration of their servers:

SILVER SPRING, Maryland, February 24 /PRNewswire/ --

- New support will accelerate development of new tools to help women protect themselves from HIV

The International Partnership for Microbicides (IPM) announced today that it has received a total of US $130 million in grants from the UK Department for International Development (DFID) and the Bill Melinda Gates Foundation, reinforcing the global commitment to address the HIV epidemic in women.

What goes on here? Was the historian Richard Hofstadter wrong in his classic Anti-Intellectualism in American Life to detect an irresistible current in our society of "resentment and suspicion of the life of the mind and of those who are considered to represent it"? Has that current weakened or been sufficiently dammed up to explain the election of a president who is reflective about history and ideas as well as about policy and practice?

BUCHAREST, February 24 /PRNewswire/ -- Lamit Company, an important satellite internet provider, launches a new solution for improving the satellite internet connections (terrestrial, wireless or bidirectional via satellite), the 2.5 STABLE version of Lamit 2Pro Advanced and Lamit 2Pro Mini Power servers. Despite the very small dimensions of the Mini Power server, it maintains all the features and characteristics of the Lamit 2Pro server's Platform. The new generation of servers includes Wireless connectivity (N type, offering an extended coverage area and maximum transfer rates) providing easier users' connection. The new servers' version also offers new encryption facilities, a better control and professional management of the users' LAN.

AUSTIN, Texas, February 24 /PRNewswire/ --

- Specifically for use with Stellaris Microcontrollers, New Software Library Provides Appliance OEMs a Fast Path to Best-in-Class Safety Compliance

INDIANAPOLIS, February 24 /PRNewswire/ --

PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) technology. The use of enantiomerically pure DOTAP Chloride shows enhanced adjuvant activity compared to the racemate. Merck Eprova AG will be providing enantiomerically pure DOTAP Chloride manufactured under cGMP for use in clinical and commercial drug products developed with PDS Biotechnology's Versamune(TM) nanoparticle technology. PDS Biotechnology will own the intellectual property rights to products incorporating the chiral DOTAP lipids for immunotherapeutic applications.

New evidence of a carnivorous killer has been found in Africa. This ancient killer almost had the misfortune of going extinct twice.

While evidence of 95-million year old therapods from Africa is quite scare making one think that each fragment would be treated like gold, this was not the case the first evidence of Carcharodontosaurus iguidensis, a newly described dinosaur from the Cenomanian of Nigeria and published in the December 2007 issue of the Journal of Vertebrate Paleontology.

CAMBRIDGE, Massachusetts, February 24 /PRNewswire/ --

Despite an overall economic contraction, network operator spending on telecom equipment in the Asia/Pacific region will rise slightly over the next 24 months, driven primarily by deployment of 3G networks in China, according to a new report from Pyramid Research (http://www.pyr.com), the telecom research arm of the Light Reading Communications Network (http://www.lightreading.com ).

GENEVA, February 24 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and Ambrx Inc, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by Ambrx through the application of its proprietary protein optimization technology, ReCODE(TM).

This second collaboration between the two companies follows a previous agreement announced in 2007 to develop ARX201, Ambrx's long-acting growth hormone product, currently in Phase II of clinical development.